Superantigens and retroviral infection: insights from mouse mammary tumor virus
Authors:
- Hans Acha-OrbeaHAHans Acha-Orbea
- H.Robson MacDonaldHMH.Robson MacDonald
- Gary A. WaandersGWGary A. Waanders
- 1 April 1994
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 15 (4) , 184-190
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Identification of an endogenous mammary tumor virus involved in the clonal deletion of Vβ2 T cellsEuropean Journal of Immunology, 1993
- Antigen-selected T-cell receptor diversity and self-nonself homologyImmunology Today, 1993
- Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein.Journal of Experimental Medicine, 1992
- Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a)Cell, 1992
- Evidence for a viral superantigen in humansNature, 1992
- Biochemical analysis of the mouse mammary tumor virus long terminal repeat product. Evidence for the molecular structure of an endogenous superantigenEuropean Journal of Immunology, 1992
- Selective Depletion in HIV Infection of T Cells that Bear Specific T Cell Receptor V β SequencesScience, 1991
- Mls — a retrovirus exploits the immune systemImmunology Today, 1991
- Superantigens: Mechanism of T-Cell Stimulation and Role in Immune ResponsesAnnual Review of Immunology, 1991
- A maternally inherited superantigen encoded by a mammary tumour virusNature, 1991